These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3085244)

  • 21. [Incidence of hepatitis B in hemophilia patients].
    Thoms J; Berles R; Syrbe G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):523-9. PubMed ID: 2446993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 23. [Unsolved therapeutic problems of hemophilia].
    Fedorova ZD; Kotovshchikova MA; Andreeva TA
    Gematol Transfuziol; 1983 Aug; 28(8):55-61. PubMed ID: 6414877
    [No Abstract]   [Full Text] [Related]  

  • 24. Impaired cell-mediated immunity in patients with classic hemophilia.
    Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
    N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
    [No Abstract]   [Full Text] [Related]  

  • 25. [Delta agent infection in hemophilia].
    Miura T; Inagaki M
    Rinsho Byori; 1987 Sep; Spec No 73():74-8. PubMed ID: 3437535
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)].
    Schwartz B; Landbeck G
    Dtsch Med Wochenschr; 1973 Oct; 98(43):2016-9. PubMed ID: 4744372
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates.
    Aznar JA; Carbonell F; Jorquera JI; Carmona E; Sánchez-Cuenca JM; Trénor A; de Andrés-Medina R; González-Molina A
    Ric Clin Lab; 1985; 15(4):315-21. PubMed ID: 3938863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis and complications in hemophilia. Introductory remarks.
    Harris CE
    Bibl Haematol; 1970; 34():97-103. PubMed ID: 5436358
    [No Abstract]   [Full Text] [Related]  

  • 31. [Analysis of various adverse effects of substitute treatment of children with hemophilia].
    Adamowicz-Salach A; Głoskowska-Moraczewska Z; Klukowska A; Kamińska D
    Pediatr Pol; 1988 May; 63(5):326-31. PubMed ID: 2851128
    [No Abstract]   [Full Text] [Related]  

  • 32. [The appearance of anti-thrombocyte and anti-leukocyte antibodies in hemophilia A patients after cryoprecipitate transfusions].
    Uteg KH; Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):771-6. PubMed ID: 64419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV, HBV and HCV seropositivity in hemophiliacs.
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune status of blood product recipients.
    Jason J; Hilgartner M; Holman RC; Dixon G; Spira TJ; Aledort L; Evatt B
    JAMA; 1985 Feb; 253(8):1140-5. PubMed ID: 3918187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia, hepatitis and HAA.
    Lewis JH
    Vox Sang; 1970; 19(3):406-9. PubMed ID: 5502767
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemophilia and acquired immune deficiency syndrome.
    Levine PH; Brettler DB; Sullivan JL
    Prog Clin Biol Res; 1985; 182():287-96. PubMed ID: 2994104
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
    Kamiya T
    Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
    [No Abstract]   [Full Text] [Related]  

  • 38. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jaundice and hepatitis B antigen-antibody in hemophilia.
    Lewis JH; Maxwell NG; Brandon JM
    Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949
    [No Abstract]   [Full Text] [Related]  

  • 40. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
    Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.